Table 2.
Demographic and clinical characteristics of 21 reported cases of post COVID ReA.
| Author | Age | Sex | Documented COVID | Duration between COVID and articular symptoms | Joints involved | No. of joints involved | CRP | Treatment |
|---|---|---|---|---|---|---|---|---|
| Yokogawa et al.4 | 57 | M | Yes | 17 | Left wrist, right shoulder, bilateral knees | 4 | 4.8 mg/dL | Spontaneous resolution |
| Parisi et al.9 | 58 | F | Yes | 25 | Ankle arthritis, Achilles tendinitis | 1 | 7.36 mg/L (0–5) | NSAIDs |
| Ono et al.10 | 50s | M | Yes | 22 | Bilateral ankles, right Achilles tendinitis | 2 | 7.4 mg/dL (0–0.14) | NSAIDs, IACS |
| Waller et al.11 | 16 | F | Yes | 14 | MCPs, wrists, shoulders, hips, knees | – | <1 | – |
| Jali12 | 39 | F | Yes | 21 | DIP, PIP of hands | – | Normal | NSAIDs |
| Coath et al.13 | 53 | M | Yes | – | Inflammatory back pain | – | 13 mg/l (<10) | IM steroids, NSAIDs |
| Liew et al.14 | 47 | M | Yes | 3 | Right knee | 1 | NSAIDs, IACS | |
| Saricaoglu et al.15 | 73 | M | Yes | 22 | Left 1st MTP, bilateral PIP and DIP of toes | 5 | Markedly elevated | NSAIDs |
| Danssaert et al.16 | 37 | F | Yes | 12 | Right hand (tenosynovitis) | – | Normal | Opioids, topical NSAIDs |
| Fragata et al.17 | 41 | F | Yes | 28 | PIP, DIP, MCP | – | Normal | Oral steroids, NSAIDs |
| Gasparotto et al.18 | 60 | M | Yes | 32 | Right ankle, knee, hip | 3 | 237 mg/dL (<6) | NSAIDs |
| Hønge et al.19 | 53 | M | Yes | 21 | Right knee, both ankles and the lateral side of the left foot | 3 | 327 mg/dL | NSAIDs, oral steroid |
| Kocyigit et al.20 | 53 | F | Yes | 29 | Left knee | 1 | 10.8 mg/dL (<10 mg/dL) | NSAIDs |
| Schenker et al.21 | 65 | F | Yes | 10 | Bilateral knees, ankles and wrists | 6 | 34.7 mg/dL | Prednisolone |
| Di Carlo et al.22 | 55 | M | Yes | 37 | Right ankle | 1 | 5.6 mg/dL | Methylprednisolone |
| Hasbani et al.23 | 25 | M | Yes | 19 | Inflammatory back pain, left ankle and right elbow | 2 | 207 mg/L | Oral prednisolone, sulphasalazine |
| Hasbani et al.23 | 57 | M | Yes | 30 | Left wrist | 1 | 28.9 mg/L | Oral prednisolone, NSAIDs |
| Sureja et al.24 | 27 | F | Yes | 14 | Bilateral knees, ankles, midfoot, right wrist, MCPs,PIPs | Approximately 10 | - | NSAIDs |
| Shokraee et al.25 | 58 | F | Yes | 15 | Right hip | 1 | 6.5 mg/L | NSAID, prednisolone |
| Gibson et al.26 | 37 | M | Yes | 35 | Bilateral wrists and PIPs | Approximately 5 | 25 mg/dL (5 mg/dL) | Oral prednisolone and NSAIDs |
| Ghauri et al.27 | 34 | M | Yes | 15 | Right knee | 1 | Elevated | NSAID, IACS |
CRP, C-reactive protein; DIP, distal interphalangeal; F, female; IACS, intra-articular corticosteroids; M, male; MCP, metacarpophalangeal; MTP, metatarsophalangeal; NSAIDs, non-steroidal anti-inflammatory drugs; PCR, polymerase chain reaction; PIP, proximal interphalangeal.